Sunscreen labels may still be confusing to majority of consumers
the ONA take:
According to results of a small study published online ahead of print in JAMA Dermatology, researchers have found that sunscreen labels may still be confusing to the majority of consumers.
For the study, researchers from Northwestern University Feinberg School of Medicine in Chicago surveyed 114 patients at a single dermatology clinic to evaluate their understanding of sunscreen labels and best practices for sun protection.
Results showed that 81.6% reported purchasing sunscreen in 2013. Of all participants, 75.4% said they purchased sunscreen in order to prevent sunburns and 65.8% bought it to prevent skin cancer.
Researchers found that only 43% understood the definition of SPF, 37.7% could correctly determine how well the sunscreen protected against skin cancer, and 22.8% could correctly identify how well the sunscreen protected against sunburns.
The findings suggest that sunscreen label terminology may still be confusing to the majority of consumers seeking to protect themselves from sunburns and skin cancer.
Sunscreen labels may still be confusing to the majority of consumers.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|